Search
Filter by content type
Filter by content year
Filter by category
BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial of Lead mRNA COVID-19 Vaccine BNT162b2 in China
November 25, 2020 - … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … mRNA COVID-19 Vaccine BNT162b2 in China … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … Lead mRNA COVID-19 Vaccine BNT162b2 in China BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial …
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
August 5, 2020 - … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based …
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
July 20, 2020 - … (excluding China, where BioNTech has a collaboration with Fosun Pharma for BNT162 for both clinical development and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; the …
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
July 1, 2020 - … (excluding China, where BioNTech has a collaboration with Fosun Pharma for BNT162 for both clinical development and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; the …
BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem COVID-19-Impfstoffkandidaten in China
August 5, 2020 - … BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem … COVID-19-Impfstoffkandidaten in China … BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem … COVID-19-Impfstoffkandidaten in China BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem …
BioNTech to Present Data from BNT311 (GEN1046) and BNT131 (SAR441000) Programs at SITC 35th Annual Meeting
October 14, 2020 - … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
October 14, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
Pfizer und BioNTech veröffentlichen erste positive Daten aus laufender deutscher Phase-1/2-COVID-19-Impfstoffstudie samt vorläufigen Ergebnissen zur T-Zell-Antwort
July 20, 2020 - … (ausgenommen China, wo BioNTech eine Partnerschaft mit Fosun Pharma für die klinische Entwicklung und … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
October 6, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
Pfizer und BioNTech veröffentlichen erste positive Daten aus laufender Phase-1/2-Studie mit mRNA-basiertem SARS-CoV-2-Impfstoffkandidaten
July 1, 2020 - … (ausgenommen China, wo BioNTech eine Partnerschaft mit Fosun Pharma für die klinische Entwicklung und … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …